A small subset of 10 to 15% of the population with clinical manifestations of HT is, in fact, negative for antibody titers
These findings collectively emphasize that while GLP-1RAs are effective in reducing FBM, strategies to preserve or enhance SMM, such as resistance training and adequate protein intake, should be integral to obesity management
While no clinical trials have firmly established its efficacy or safety in humans, the volume of in-vitro and animal model data provides a compelling rationale for its continued investigation
Safely weaning off GLP-1 medications requires gradual dose reduction over weeks or monthsnever stopping abruptly
Left untreated, Lyme-induced inflammation damages cells, tissues, and organs, inducing widespread bodily dysfunction